Joseph K. Salama, Michael D. Mix, Corinne Faivre-Finn, Andrea Bezjak, Jeffrey A. Bogart
The treatment landscape for treating NSCLC and SCLC has been shaped by significant advances in imaging, radiotherapy technology, tumor biology, and systemic therapy. This review evaluates the role of radiotherapy in contemporary lung cancer management, drawing on evidence from key prospective trials conducted in the past 2 decades.